| CAS NO: | 2044679-53-8 |
| 包装 | 价格(元) |
| 1mg | 电议 |
| 5mg | 电议 |
| 生物活性 | Tepoditamab (MCLA-117) is a bispecific monoclonal antibody that binds toCLEC12Aof myeloid cells andCD3of cytotoxic T cells. Amongothers, CLEC12A is a myeloid differentiation antigen. Tepoditamab (MCLA-117) kills AML leukaemia mother cells and AML leukaemia stem cells, induces T cell-mediated proliferative lysis of AML cells and can be used in acute myeloid leukaemia (AML) research[1]. |
| CAS 号 | 2044679-53-8 |
| 储存方式 | Please store the product under the recommended conditions in the Certificate of Analysis. |
m.cnreagent.com